The Power of Key Business Questions
In our biopharma world, we frequently hear the term “Key Business Questions…
The Underappreciated Value of New Product Planning
The value of New Product Planning (NPP) is often overlooked, but it plays a…
Biopharma Annual Planning Success: Close Your Rings Year-Round
How do we think about biopharma annual planning differently? The analogy we…
The Power of Target Product Profiles: Three Case Studies
In the biopharma industry, the Target Product Profile (TPP) is a critical tool…
Freedom to Lead
In a recent internal planning session for Corval, our new cloud-based commercialization planning platform, we debated whether the term “Freedom to…
Pandemic-Inspired Thought Bubbles
As we emerge, slowly, into a new phase of the pandemic, there are many “thought bubbles” popping up — viewpoints, concerns, and ideas that we share…
Rare Disease Patient Advocacy and Medical Affairs: Why They Come First
Among all the days of the calendar, February 29th is the rarest of them all. That's why, back in 2008, on the 25th anniversary of the Orphan Drug…